Literature DB >> 1481360

Humanized animal viruses with special reference to the primate adaptation of morbillivirus.

E Norrby1, J Kövamees, M Blixenkrone-Möller, B Sharma, C Orvell.   

Abstract

This review article discusses the evolution of human viruses with special reference to paramyxoviruses. This family of viruses causes epidemics representing the dissemination of infection from one acutely infected host to the next. Since there is no repository for human paramyxoviruses in animals or in the form of persistent infections in man, the history of epidemics afflicting human civilization is short, presumably not exceeding 4000-5000 years. Evolutionary relationships can be deduced for comparison of nucleotide sequences of genes or even complete genomes. The present paramyxovirus genus will probably in the future be divided into two separate genera. In the genus morbillivirus, two pairs of more closely related virus types can be distinguished: canine and phocid viruses, and rinder-pest and measles viruses, respectively. It is speculated that recombination events may have occurred in the evolution of the morbillivirus archetype.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1481360     DOI: 10.1016/0378-1135(92)90055-x

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  3 in total

Review 1.  Role of viruses in human evolution.

Authors:  Linda M Van Blerkom
Journal:  Am J Phys Anthropol       Date:  2003       Impact factor: 2.868

2.  Reproductive trade-offs in extant hunter-gatherers suggest adaptive mechanism for the Neolithic expansion.

Authors:  Abigail E Page; Sylvain Viguier; Mark Dyble; Daniel Smith; Nikhil Chaudhary; Gul Deniz Salali; James Thompson; Lucio Vinicius; Ruth Mace; Andrea Bamberg Migliano
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-11       Impact factor: 11.205

3.  Did viral disease of humans wipe out the Neandertals?

Authors:  Horst Wolff; Alex D Greenwood
Journal:  Med Hypotheses       Date:  2010-02-20       Impact factor: 1.538

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.